ING Group’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q2
Sell
-10,949
Closed -$735K 642
2014
Q1
$735K Buy
+10,949
New +$735K ﹤0.01% 590